Search

Your search keyword '"Pipitone N"' showing total 462 results

Search Constraints

Start Over You searched for: Author "Pipitone N" Remove constraint Author: "Pipitone N"
462 results on '"Pipitone N"'

Search Results

1. Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study

2. OP0014 TRANSCRIPTS EXPRESSED IN TEMPORAL ARTERY BIOPSIES ASSOCIATED WITH RESPONSE TO THERAPY IN PATIENTS WITH GIANT CELL ARTERITIS

3. POS0115 EOSINOPHILIC GIANT CELL ARTERITIS: A DIFFERENT SUBSET OF DISEASE?

4. OP0025 GENOME-WIDE DNA METHYLATION STUDY REVEALS SPECIFIC SIGNATURES IN THE AFFECTED ARTERIAL TISSUE OF GIANT CELL ARTERITIS PATIENTS

6. POS0728 EFFECTIVENESS AND SAFETY OF A 26 WEEK TAPER REGIMEN OF GLUCOCORTICOID IN NEWLY-DIAGNOSED GCA PATIENTS: A REAL LIFE EXPERIENCE

7. POS1221 CLINICAL FEATURES OF PATIENTS WITH ANTI-SYNTHETASE SYNDROME AND DERMATOMYOSITIS-ASSOCIATED SKIN MANIFESTATIONS: RESULTS FROM THE MYONET REGISTRY

8. Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies

13. The International Criteria for Behçetʼs Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria

15. THU0314 RELAPSES AND LONG-TERM REMISSION IN LARGE VESSEL GIANT CELL ARTERITIS IN NORTHERN ITALY: CHARACTERISTICS AND PREDICTORS IN A LONG-TERM FOLLOW-UP STUDY

17. Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study

18. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria—methodological aspects

29. Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

32. Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study

37. Timing of onset affects arthritis presentation pattern in antisyntethase syndrome

38. Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology

39. Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise

40. Interferon Alpha-2a Treatment for Post-Uveitic Refractory Macular Edema.

44. CLINICAL FEATURES OF PATIENTS WITH ANTI-SYNTHETASE SYNDROME AND DERMATOMYOSITIS-ASSOCIATED SKIN MANIFESTATIONS: RESULTS FROM THE MYONET REGISTRY.

45. TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI

47. Do dermatomyositis and polymyositis affect similar thigh muscles? A comparative MRI-based study

48. Tocilizumab in glucocorticoid-naive large-vessel vasculitis

50. Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers

Catalog

Books, media, physical & digital resources